Autopsy report · NCT02400645

TAP Block With Liposomal Bupivacaine Versus Pre-incisional Wound Infiltration With Bupivacaine for Postoperative Pain

“It was determined that one member of the team had falsified data.”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 1 year 2 months before it stopped.
• 69 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 1

Sponsor

University of Tennessee

Sponsor type

University, hospital or other

Conditions

Postoperative Pain

Interventions

Pre-incisional wound infiltration; Laparoscope to place TAP block with liposomal bupivacaine; Liposomal bupivacaine; Bupivacaine; Ketorolac

Participants

69

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.